Search bioRxiv⌕ Search

Biology subjects

Mandoli, A.

Publications and source records attributed to Mandoli, A..

3 recordsLinked to original sources

FlowWeb, a free, web-based platform for flow cytometry data analysis

Flow cytometry is widely used for high-throughput single-cell analysis. However, its data analysis relies on either costly commercial software or programming-intensive open-source tools. To bridge this gap, we developed FlowWeb, a freely accessible, web-based platform that combines the flexibility of the R/Bioconductor ecosystem with an intuitive graphical user interface. FlowWeb enables integrated workflows for data handling, quality control, gating, visualization and statistical analysis within a unified environment. FlowWeb integrates raw data, metadata, and analytical state within synchronized Bioconductor structures, enabling coherent analysis and visualization workflows. FlowWeb supports both manual and automated data-driven gating workflows. To evaluate its performance, we applied FlowWeb to an in-house flow cytometry dataset and compared its automated cell cycle and gating workflows to established commercial tools. FlowWebs automated cell cycle workflow produced consistent and reproducible results across replicates and demonstrated high concordance with reference analyses, highlighting the platforms robustness. FlowWebs advanced visualization tools include a wide range of fully customizable individual, overlay, and statistical plots. To enhance usability and reproducibility, the FlowWeb platform provides optional user-accounts that allow storage of reusable configurations, including quality control presets, gating definitions, and plot templates. By lowering technical barriers without compromising analytical rigor, FlowWeb facilitates accessible, reproducible, and scalable flow cytometry data analysis for a broad range of users in research and clinical settings.

cell biology↗

Deciphering the phenotypic heterogeneity and drug response in cancer cells using genome-wide activity and interaction of chromatin domains.

The effect of co-localization of genes in the topologically associated domains (TADs) and their activity as a regulatory unit in cancer samples and cells, together with drug-response, needs comprehensive analysis. Here, we analyzed the activity of TADs using cancer-cell transcriptomes along with chromatin-interaction and epigenome profiles to understand their relationship with drug-response. Our analysis of 819 cancer cell-line transcriptomes revealed that their response to multiple drugs was more correlated with the activity of individual TADs than genes. Applying our approach to 9014 cancer patients data (20 different cancer types) also revealed a higher association between survival and the activity of thousands of individual TADs in comparison to their genes. CRISPR-mediated knock-out of regulatory sites inside a TAD associated with cisplatin-response of oral cancer cells and discovery of primate-specific gain of synteny of genes within a TAD containing EGFR gene and its contribution towards cancer malignancy demonstrate greater utility of TAD-activity based analysis.

cancer biology↗

CBFβ-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1

The inv(16) acute myeloid leukemia associated CBF{beta}-MYH11 fusion is proposed to block normal myeloid differentiation, but whether this subtype of leukemia cells is poised for a unique cell lineage remains unclear. Here, we surveyed the functional consequences of CBF{beta} - MYH11 in primary inv(16) patient blasts, upon expression during hematopoietic differentiation in vitro and upon knockdown in cell lines by multi-omics profiling. Our results reveal that primary inv(16) AML cells share common transcriptomic signatures and epigenetic determiners with megakaryocytes and erythrocytes. Using in vitro differentiation systems, we reveal that CBF{beta}-MYH11 knockdown interferes with normal megakaryocyte maturation. Two pivotal regulators, GATA2 and KLF1, are identified to complementally occupy RUNX1 binding sites upon fusion protein knockdown, and overexpression of GATA2 partly restores megakaryocyte directed differentiation suppressed by CBF{beta}-MYH11. Together, our findings suggest that in inv(16) leukemia, the CBF{beta}-MYH11 fusion inhibits primed megakaryopoiesis by attenuating expression of GATA2/KLF1 and interfering with a balanced transcriptional program involving these two factors.

cancer biology↗